Guidelines versus trial-evidence for statin use in primary prevention: The Copenhagen General Population Study
Open Access
- 1 January 2022
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 341, 20-26
Abstract
No abstract availableKeywords
Funding Information
- National Institute for Health and Care Excellence
- Center for Computational Sciences, University of Kentucky
- American Heart Association
- Canadian Cardiovascular Society
- Gentofte Hospital
- European Society of Contraception and Reproductive Health
- American Chemistry Council
- State Key Laboratory of Environmental Adaptability for Industrial Products
This publication has 23 references indexed in Scilit:
- 25‐Hydroxyvitamin D and symptomatic ischemic stroke: An Original Study and Meta‐AnalysisAnnals of Neurology, 2012
- Number Needed to Treat With Rosuvastatin to Prevent First Cardiovascular Events and Death Among Men and Women With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive ProteinCirculation: Cardiovascular Quality and Outcomes, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2BMJ, 2008
- General Cardiovascular Risk Profile for Use in Primary CareCirculation, 2008
- Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trialThe Lancet, 2006
- Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysisBMJ, 2003
- Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialThe Lancet, 2003
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995